[
sinopharm
]Latest from sinopharm
Omicron routs J&J vaccine in lab study, may evade Sinovac and BioNTech too
A study, conducted by scientists at the microbiology department of the University of Hong Kong, showed that insufficient antibodies were generated by the Sinovac and BioNTech products to fend off Omicron.

Published on Dec 15, 2021 01:26 PM IST
Written by Joydeep Bose | Edited by Avik Roy, Hindustan Times, New Delhi
China's Covid-19 vaccine Sinopharm less effective in protecting the elderly
This is not the first time questions have been raised about the efficacy of the vaccine, which was given a greenlight by the World Health Organization in May and is being used in more than 50 countries

Hungary concerned over efficacy of China's Sinopharm vaccine
Budapest residents who were fully vaccinated got free test inspecting the development of antibodies to defend Covid-19, out of which 60 residents who received China's Sinopharm vaccine hadn't developed antibodies.

China fumes after Nepal's media exposes price of procuring Sinopharm jabs
Nepal had to sign a non-disclosure agreement with China over the procurement of Sinopharm Covid-19 vaccines. However, a report by a regional publication revealed the price of procurement, citing confirmation from two ministers and two government secretaries, much to Beijing's displeasure

Sinopharm can provide over billion Covid-19 vaccine doses to world: Chairman
That level of supply capability assumes vaccination demand in China is being met, China National Pharmaceutical Group's chairman Liu Jingzhen said.
